Medical devices, healthcare technology and the business of care
510(k) clearance · K262343

Dynavisc

Fziomed, Inc. · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONK262343

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for Dynavisc, a traditional 510(k) submitted by Fziomed, Inc. of San Luis Obispo, California, under number K262343. The record lists the device classification name as Mesh, Surgical, Absorbable, Orthopaedics, Reinforcement Of Tendon, regulation number 878.3300, and classification product code OWW. The application was received on 07/10/2026 and decided on 10/28/2026; SESE means the device was cleared for marketing, not granted premarket approval.

The record lists the regulation medical specialty as General & Plastic Surgery and the 510(k) review panel as Orthopedic. It states the submission was not reviewed by a third party, is not a combination product, and has no authorized predetermined change control plan. The public record does not describe the specific device components, materials, or any changed item, and no summary statement is present, so the basis for the equivalence determination remains unknown from this source.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Oct 28, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262343
Regulatory pathway
510(k) premarket notification
Applicant
Fziomed, Inc.
Product code
OWW
Decision code
SESE
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Mesh, Surgical, Absorbable, Orthopaedics, Reinforcement Of Tendon.

Applicant
Fziomed, Inc.
Product code
OWW
FDA device class
2

FDA decision timeline

  1. K262343 received

    Application receipt date recorded by FDA.

  2. K262343 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code OWW

Product / regulatory recordCompanyPathwayDecision dateSource
BioChargeK263682
Nanofiber Solutions, LLC510(k) clearanceNov 5, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Fziomed, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Luis Obispo, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records